Original Research
Accepted on 28 Aug 2025
Integrated Multi-Omics Analysis Reveals Glycolytic Signature Predicts Pan-Cancer Immune Checkpoint Inhibitor Response and LDHA as a Combinatorial Target in Fumarate Hydratase-Deficient Renal Cell Carcinoma
in Cancer Immunity and Immunotherapy